2019
DOI: 10.1016/j.abb.2019.06.009
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
32
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(36 citation statements)
references
References 66 publications
0
32
0
1
Order By: Relevance
“…Firstly, the letrozole-induced PCOS model used in this study has been widely utilized to assess the effects and the mechanisms of interventions on precautions and pathogenesis in PCOS ( 46 48 ). Letrozole, an aromatase inhibitor, induces hyperandrogenemia by reducing the conversion of T to estrogen ( 49 ).…”
Section: Discussionmentioning
confidence: 99%
“…Firstly, the letrozole-induced PCOS model used in this study has been widely utilized to assess the effects and the mechanisms of interventions on precautions and pathogenesis in PCOS ( 46 48 ). Letrozole, an aromatase inhibitor, induces hyperandrogenemia by reducing the conversion of T to estrogen ( 49 ).…”
Section: Discussionmentioning
confidence: 99%
“…It was shown that Se was implicated in regulating the physiology of uterine smooth muscles potentially via modulating the expression of Selenon, Selenot, and Selenow [41,42], and the G protein Rho (RhoA)/Rho kinase (ROCK) signaling pathway in mice [43]. However, only recently have researchers paid attention to potential role of Se in ovarian physiology and embryo development [9,28,[44][45][46][47][48][49][50]. Interestingly, when exploring the mainstream literature, with the exclusion of one study reporting the beneficial effects of Se supplementation on sperm parameters in aging mice [51], no study has yet elucidated how Se might ameliorate the reproductive function in aging mammalian models, let alone the aged females.…”
Section: Introductionmentioning
confidence: 99%
“…It has been observed to possess a cardioprotective property, along with diminishing before-and after-meal glucose levels, assisting in reduction of weight and diminishing lipid levels in plasma. 7,8 A preclinical study of cardiac failure and myocardial infarction (MI) has demonstrated that metformin expands the resilience of the heart to ischemia-reperfusion damage and, after infarction, diminishes the advancement of heart failure. 9,10 The UK Prospective Diabetes Study (UKPDS) showed that metformin beneficially affects diverse cardiovascular hazard factors.…”
Section: Introductionmentioning
confidence: 99%
“…Metformin is a medication utilized in patients with Type 2 diabetes (T2D). It has been observed to possess a cardioprotective property, along with diminishing before‐ and after‐meal glucose levels, assisting in reduction of weight and diminishing lipid levels in plasma . A preclinical study of cardiac failure and myocardial infarction (MI) has demonstrated that metformin expands the resilience of the heart to ischemia–reperfusion damage and, after infarction, diminishes the advancement of heart failure .…”
Section: Introductionmentioning
confidence: 99%